Susquehanna International Group’s Rosetta Genomics Ltd. ROSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,350
Closed -$37K 10352
2014
Q4
$37K Sell
1,350
-3,733
-73% -$121K ﹤0.01% 9422
2014
Q3
$215K Sell
5,083
-717
-12% -$32.6K ﹤0.01% 8566
2014
Q2
$302K Sell
5,800
-417
-7% -$20.7K ﹤0.01% 8372
2014
Q1
$372K Buy
+6,217
New +$321K ﹤0.01% 7246
2013
Q4
Sell
-1,208
Closed -$46K 9582
2013
Q3
$46K Sell
1,208
-950
-44% -$38.5K ﹤0.01% 8249
2013
Q2
$88K Buy
+2,158
New +$95.9K ﹤0.01% 7841

Other funds holding ROSG

Susquehanna International Group's ROSG Position: Q1 2018 in Review

Susquehanna International Group sold out of Rosetta Genomics Ltd. (ROSG) in Q1 2018, closing a stake of 36,171 shares — an estimated $20K sold.

Susquehanna International Group first reported a position in ROSG in Q1 2014 and held it in 7 quarters. The position peaked at $247K in Q2 2014. 8 funds tracked by Wall St. Rank hold ROSG as of Q1 2018.

  • Susquehanna International Group reported no remaining Rosetta Genomics Ltd. position as of Q1 2018 after selling out during the quarter.
  • Susquehanna International Group sold 36,171 Rosetta Genomics Ltd. shares in Q1 2018, an estimated $20K.
  • Susquehanna International Group first reported a position in Rosetta Genomics Ltd. in Q1 2014 and held it in 7 quarters.
  • Susquehanna International Group's Rosetta Genomics Ltd. position peaked at $247K in Q2 2014.
  • 8 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q1 2018.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.